Long‐term delirium and survival outcomes in patients treated with <scp>GLP</scp> ‐1 receptor agonists versus metformin in type 2 diabetes: A population‐based cohort study
GLP-1 RA use was initially associated with a lower risk of delirium, but this association reversed over time. Subgroup variations suggest individualised treatment considerations. Metformin remains a preferred option given its stable cognitive and survival benefits.
Authors
- Szu‐Yuan Wu (ORCID: https://orcid.org/0000-0001-5637-558X)
- Mengrong Miao (ORCID: https://orcid.org/0000-0002-6956-8599)
- Shuang Lv
- Zhongyuan Lu (ORCID: https://orcid.org/0000-0002-0897-7006)
- Wan‐Ming Chen (ORCID: https://orcid.org/0009-0009-6628-0635)
- Yi Yang (ORCID: https://orcid.org/0000-0002-9400-1850)
- Xiaoling Wang
- Jianqiang Zhang (ORCID: https://orcid.org/0000-0002-9331-4601)
- Mingyang Sun (ORCID: https://orcid.org/0000-0003-3181-6793)
Institutions
- Fu Jen Catholic University (TW)
- Asia University (TW)
- Luodong Poh-Ai Hospital (TW)
- Zhengzhou University (CN)
- Henan Provincial People's Hospital (CN)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-05-07
- DOI
- https://doi.org/10.1111/dom.16434
- Citations
- 1
- Primary Topic
- Intensive Care Unit Cognitive Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.55